
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Anagrelide may cause a range of side effects during treatment, including adverse reactions in the cardiovascular system, digestive system, nervous system, and others. Different pat···【more】
Article source:Captain MedicineRelease date:2026-03-30Recommended:234
During treatment with anagrelide, certain adverse reactions may occur. Depending on patient response and needs, the physician may adjust the dosage of anagrelide. Understanding the···【more】
Article source:Captain MedicineRelease date:2026-03-30Recommended:243
As a targeted therapy, ivosidenib may cause certain side effects while exerting its anti-tumor effects.Less Severe Side EffectsCommon side effects include cracked lips, decreased a···【more】
Article source:Captain MedicineRelease date:2026-03-30Recommended:190
Ivosidenib is a prescription medication. Patients should fully understand the drug information before use. The Ivosidenib Medication Guide covers key aspects such as patient select···【more】
Article source:Captain MedicineRelease date:2026-03-30Recommended:255
The use of Anagrelide requires attention to its potential side effects, mitigation methods, and proper storage to ensure therapeutic efficacy and reduce safety risks.I. Detailed Ex···【more】
Article source:Captain MedicineRelease date:2026-03-27Recommended:177
Anagrelide, as a platelet-reducing medication, plays an important role in the treatment of specific hematologic disorders. Clinical application requires strict adherence to its ind···【more】
Article source:Captain MedicineRelease date:2026-03-27Recommended:251
As a specialized platelet-lowering medication, Anagrelide also plays an important role in the clinical management of secondary thrombocythemia.I. Specifications for Anagrelide Usag···【more】
Article source:Captain MedicineRelease date:2026-03-27Recommended:224
Pemigatinib is a kinase inhibitor indicated for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibro···【more】
Article source:Captain MedicineRelease date:2026-03-27Recommended:245
Side Effects of AxitinibUnderstanding the possible side effects that may occur during treatment with axitinib can help patients enhance self-monitoring awareness and improve treatm···【more】
Article source:Captain MedicineRelease date:2026-03-26Recommended:258
Side Effects of TazemetostatAs a drug used for treating certain tumors, tazemetostat may cause varying degrees of side effects in some patients due to individual differences, while···【more】
Article source:Captain MedicineRelease date:2026-03-26Recommended:218
Larotrectinib may cause a range of side effects and adverse reactions, varying from mild to severe. Understanding these potential side effects is crucial for patients undergoing tr···【more】
Article source:Captain MedicineRelease date:2026-03-26Recommended:250
The specific treatment regimen for tazemetostat should be determined by a qualified physician based on the patient's condition, body weight, liver and kidney function, concomit···【more】
Article source:Captain MedicineRelease date:2026-03-26Recommended:201
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended:[list:visits]2026-30-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643